Heart Disease News and Research

Latest Heart Disease News and Research

Saint Louis University scientists identify chemical that triggers Parkinson's disease

Researchers at the Saint Louis University School of Medicine have discovered the key brain chemical that causes Parkinson's disease - a breakthrough finding that could pave the way for new, far more effective therapies to treat one of the most common and debilitating neurological disorders.

30 Oct 2007

Transplant rejection drug boosts the risk of birth defects

Authorities in the United States have issued a warning with regard to a drug used to prevent the rejection of transplanted organs.

30 Oct 2007

Most people living longer except rheumatoid arthritis sufferers

New research by the Mayo Clinic has found that while most people are living longer the same is not true for sufferers from rheumatoid arthritis.

30 Oct 2007

Comparison of mortality trends among rheumatoid arthritis subjects

An autoimmune inflammatory disease that takes a progressive toll on the heart, kidney and liver as well as the joints, rheumatoid arthritis (RA) is associated with a high risk of early death.

29 Oct 2007

Ethnic differences in sleep quality and blood pressure

In the United States, African Americans have higher blood pressure and are at greater risk of hypertension than whites.

29 Oct 2007

Research clarifies origin of mammalian network of lymphatic vessels

Investigators at St. Jude Children's Research Hospital settled a century-old debate on the origin of the mammalian lymphatic vasculature - the network of vessels and capillaries critical to various essential housekeeping functions in the body.

29 Oct 2007

Do statins make radiation more effective at curing prostate cancer?

Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs commonly used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), compared to those who don't take these medications (66 percent), according to a study presented at a scientific session October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

Early autism detection

In an attempt to spot autism earlier, the American Academy of Pediatrics has recently recommended that all children be screened for autism twice by age 2 - advice that many St. Louis families already heed thanks to a partnership between Saint Louis University and Parents as Teachers.

29 Oct 2007

Organic food a far better health option

The study involved researchers growing fruits and vegetables on a 725 acre area where fields were split into two so that conventional and organic produce could be grown side by side.

29 Oct 2007

Advancement in radiation oncology treatment called IMRT improves care, avoids healthy tissue

New advancements in a radiation oncology treatment called IMRT (intensity modulated radiation therapy) are proving far superior to standard radiation procedures used today in safeguarding the healthy tissues surrounding cancerous tumors, and thus improving patient care.

28 Oct 2007

FDA issues communication on ongoing safety review of Aprotinin injection

Last week, FDA was notified that a Canadian research group stopped a study on Trasylol because the drug appeared to increase the risk for death compared to the other antifibrinolytic drugs used in the study. Antifibrinolytic drugs help slow the breakdown of blood clots and subsequent excessive bleeding.

28 Oct 2007

Stanford researchers get precise picture of cell target for drugs

More than half of all drugs given to patients work by targeting a particular type of "docking station," or receptor, found on body cells, to steer the cell's machinery toward healing an illness.

25 Oct 2007

Obesity risks increase after menopause

Postmenopausal women are at an age when the incidence and exacerbation of the chronic health conditions associated with obesity become more prevalent.

25 Oct 2007

Medical College of Wisconsin receives grant to study infantile hemangiomas

The Food and Drug Administration (FDA) has awarded the Medical College of Wisconsin in Milwaukee a three-year, $1 million Orphan Products Development grant to study infantile hemangiomas – a vascular tumor of the skin or internal organs.

25 Oct 2007

Low-density lipoprotein may contribute to vascular diseases

Low-density lipoprotein (LDL), a transporter of cholesterol, may also contribute to vascular diseases by a previously unidentified mechanism, according to a report published online this week in EMBO reports.

25 Oct 2007

Role of cholesteryl ester hydrolase in reducing heart disease identified

Virginia Commonwealth University researchers have identified the role of a key enzyme called CEH in reducing heart disease, paving the way for new target therapies to reduce plaques in the arteries and perhaps in the future, help predict a patient's susceptibility to heart disease.

24 Oct 2007

Grape seed supplement studied for cardiovascular health benefits

Could some of the natural chemicals found in plants be powerful enough to improve cardiovascular health?

24 Oct 2007

Uvulopalatopharyngoplasty may help those with obstructive sleep apnea

A procedure known as uvulopalatopharyngoplasty (UPPP) may help some patients improve or even eliminate their obstructive sleep apnea (OSA), according to a new study.

24 Oct 2007

The financial burdens of overweight and obesity among elderly Americans

What many Americans eat and how little they exercise could wind up costing them - and American taxpayers - some serious money. Moreover, the overweight and obese may lose months from their lifespans.

24 Oct 2007

Anticoagulant bivalirudin following angioplasty in heart attack patients reduces adverse events and bleeding

Late-breaking data presented at TCT 2007, the scientific symposium of the Cardiovascular Research Foundation (CRF), show that the use of the anticoagulant bivalirudin following angioplasty in heart attack patients reduces net adverse clinical events by 24 percent compared to the standard treatment, and significantly reduces major bleeding that occurs after angioplasty by 40 percent.

24 Oct 2007